2.HPLC-fluorescent spectrometric determination of serum mexiletine concentration after derivatization with fluram.
Hui ZHANG ; Chen YU ; Gang-yi LIU ; Jing-ying JIA ; You-cai HONG ; Xiu-rong XU
Acta Pharmaceutica Sinica 2003;38(3):215-217
AIMTo establish an HPLC-fluorescent spectrometric method for the determination of mexiletine hydrochloride in plasma after derivatization with fluram.
METHODSFluram acetone solution was added to the deproteinized plasma with acetone to obtain the derivative of mexiletine. The HPLC method was performed on a column of Allitima C18 (150 mm x 4.6 mm, 5 microns) with the mobile phase of methanol-water-diethylamine-phosphoric acid buffer (2.4 mol.L-1, pH 4.0) (70:28:2), and the detective wavelength were set at Ex 392 nm and Em 480 nm.
RESULTSMexiletine has a liner range over the concentration range from 0.100-6.400 mg.L-1. The lowest detectable concentration of this method was 5 micrograms.L-1 (S/N > or = 4). The intra-day and inter-day RSDs were 1.34%-5.31%, respectively.
CONCLUSIONThis method is simple, selective and can be used for therapeutic drug monitoring (TDM) and pharmacokinetic studies of mexiletine.
Anti-Arrhythmia Agents ; blood ; pharmacokinetics ; Chromatography, High Pressure Liquid ; methods ; Fluorescamine ; chemistry ; Humans ; Mexiletine ; blood ; pharmacokinetics
4.Acute amiodarone syndrome after a single intravenous amiodarone bolus.
Xin Rong NG ; Liang Yi WEE ; Veerendra CHADACHAN
Singapore medical journal 2012;53(11):e225-7
Acute amiodarone toxicity after a single dose of intravenous amiodarone is very rarely seen. We report the case of a 64-year-old Chinese man who presented with atrial fibrillation and fluid overload due to congestive cardiac failure. He was treated with a single bolus dose of intravenous amiodarone, after which he developed elevated serum transaminases, coagulopathy, thrombocytopenia and acute renal failure. His parameters returned to normal after 25 days and his recovery was uneventful.
Acute Kidney Injury
;
chemically induced
;
Amiodarone
;
adverse effects
;
Anti-Arrhythmia Agents
;
adverse effects
;
Atrial Fibrillation
;
drug therapy
;
Blood Coagulation Disorders
;
chemically induced
;
Heart Failure
;
complications
;
drug therapy
;
Humans
;
Male
;
Middle Aged
;
Thrombocytopenia
;
chemically induced
;
Transaminases
;
blood
;
Treatment Outcome
5.Effect of fructose-1,6-diphosphete on myocardial preservation during pulmonary operations.
Xiang-hui XU ; Ye-tian CHANG ; Li LI ; Jing LI ; Dong-mei ZHANG ; Xiao-hua ZOU
Journal of Central South University(Medical Sciences) 2008;33(10):966-969
OBJECTIVE:
To investigate the effect of fructose-1,6-diphosphete(FDP) on myocardial preservation in pulmonary operations.
METHODS:
One hundred and six patients undergoing selective pulmonary lobectomy or segmentectomy were randomly divided into 2 groups with 53 patients each. FDP 200 mg/kg was infused intravenously before anesthesia in the FDP group, while 5% glucose with the same volume was given instead of FDP in the control group. ECGs were monitored from before the anesthesia to 72 h after the operation;the time and type of arrhythmia were recorded. Blood samples were taken before the operation (T0), immediately after the operation(T1), at 24 h(T2),48 h(T3)and 72 h(T(4)) after the operation to determine plasma creatine kinase isoenzyme MB(CK-MB) and cardiac troponin I(cTnI) concentrations.
RESULTS:
The incidence of arrhythmia in FDP group (35 times) was significantly lower than that in the control group(67 times). The incidence of all types of arrhythmia in the FDP group was also significantly lower than that in the control group. The concentrations of CK-MB and cTnI in the FDP group were significantly lower than those in the control group at T1, T2, T3, and T4.
CONCLUSION
FDP is effective for myocardial preservation in pulmonary operations.
Aged
;
Anti-Arrhythmia Agents
;
therapeutic use
;
Arrhythmias, Cardiac
;
etiology
;
prevention & control
;
Creatine Kinase, MB Form
;
blood
;
Female
;
Fructosediphosphates
;
therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Pneumonectomy
;
adverse effects
;
Troponin I
;
blood
6.The new progress of the study about volatile oil of the angelica.
Jun-Rong DU ; Bo BAI ; Yan YU ; Cheng-Yuan WANG ; Zhong-Ming QIAN
China Journal of Chinese Materia Medica 2005;30(18):1400-1406
To summarize the new progress of the study about volatile oil of the angelica, including the distillable methods, the analysis of the chemical components, the pharmacological effects and the clinical applications. We tracked and searched the correlative references and study reports about volatile oil of the angelica in CNKI data base(1994-2004) and Medline data base (1997-2004). We summarized and compared the different distillable methods of volatile oil of the angelica, meanwhile we summarized many study reports about the analysis of the chemical components of volatile oil of the angelica and it's pharmacological effects, including the toxicity of the volatile oil and it's effects on the uterus smooth muscle, cardiovascular system, respiratory system, central nerve system and immune system. Finally we summarized the clinical application of the volatile oil of the angelica. There are three distillable methods of volatile oil of the angelica . The harvest efficiency of volatile oil is different with different distillable methods. The chemical components are very complicated and the new chemical components are separated and identified. The volatile oil has bidirectional effects on the uterus smooth muscle. It can inhibit the contraction of the uterus smooth muscle induced by different mechanisms. Meanwhile it can depress the blood pressure and ameliorate the cardiac ischemia. The volatile oil can resist the arrhythmia and asthma, restrain the central system, improve the immune function. Nowadays the volatile oil of the angelica is applied to therapy the dysmenorrhea and disorder of the catamenia. The chemical components of the volatile oil of the angelica are very complicated, moreover the pharmacological effects of the volatile oil are comprehensive. People make the new progress of the study about volatile oil of the angelica.
4-Butyrolactone
;
analogs & derivatives
;
isolation & purification
;
pharmacology
;
Angelica
;
chemistry
;
Animals
;
Anti-Arrhythmia Agents
;
pharmacology
;
Anti-Asthmatic Agents
;
pharmacology
;
Anti-Inflammatory Agents, Non-Steroidal
;
pharmacology
;
Blood Pressure
;
drug effects
;
Drugs, Chinese Herbal
;
chemistry
;
isolation & purification
;
pharmacology
;
Dysmenorrhea
;
drug therapy
;
Female
;
Humans
;
Male
;
Muscle Contraction
;
drug effects
;
Muscle, Smooth
;
drug effects
;
Oils, Volatile
;
chemistry
;
isolation & purification
;
pharmacology
;
Plants, Medicinal
;
chemistry
;
Uterus
;
drug effects
7.Metabonomic phenotype of "formula corresponding to pattern types" based on "qi and yin deficiency pattern" of myocardial ischemia rat model.
Bei YAN ; Ji-Ye A ; Hai-Ping HAO ; Guang-Ji WANG ; Lin-Sheng LIU ; Wei-Bin ZHA ; Ying ZHANG ; Sheng-Hua GU
Acta Pharmaceutica Sinica 2011;46(8):976-982
In order to explore the scientific connotation of "Fangzhengduiying (formula corresponding to pattern types)", "Qiyinliangxuzheng (Qi and Yin deficiency pattern)" of myocardial ischemia rat model and GC-TOF/MS based metabonomic method were used for comparing the effects of Sheng-mai injection, Salvia injection and propranolol in the present study. After data processing and pattern recognition, Sheng-mai injection showed better efficacy than the other two drugs in accordance with not only visual observation from PLS-DA scores plots but also the number of abnormal endogenous compounds restored to the normal level. Further studies showed that Sheng-mai injection could normalize the level of plasma endothelin-1, the index related to cardiovascular diseases and sleep disorders, which verified the results of metabonomics. Finally, the regulated metabolites and related metabolic pathways were analyzed, and it was supposed that the effects of Sheng-mai injection involved in the alternation of energy metabolism, lipid metabolism, amino acids metabolism, and so on. These findings provided scientific evidence to Shengmai "Fang" used for "Qi and Yin deficiency pattern" correspondingly, indicating that metabonomics has great potential in traditional Chinese medical research, which provides a novel approach and way to modernization of traditional Chinese medicine.
Animals
;
Anti-Arrhythmia Agents
;
pharmacology
;
Drug Combinations
;
Drugs, Chinese Herbal
;
administration & dosage
;
isolation & purification
;
pharmacology
;
Endothelin-1
;
blood
;
Gas Chromatography-Mass Spectrometry
;
methods
;
Injections
;
Male
;
Medicine, Chinese Traditional
;
Metabolomics
;
methods
;
Myocardial Ischemia
;
blood
;
metabolism
;
pathology
;
Panax
;
chemistry
;
Plants, Medicinal
;
chemistry
;
Propranolol
;
pharmacology
;
Qi
;
Rats
;
Rats, Sprague-Dawley
;
Salvia
;
chemistry
;
Schisandraceae
;
chemistry
;
Yin Deficiency
;
metabolism
8.Antiarrhythmic effect of TJ0711.
Xiao-Jing ZHANG ; Jun QIU ; Gao LI
Acta Pharmaceutica Sinica 2014;49(3):419-426
To study the antiarrhythmic effect of the newly developed alpha/beta-blocker TJ0711, a variety of animal models of arrhythmia were induced by CaCl2, ouabain and ischemia/reperfusion. Glass microelectrode technique was used to observe action potentials of right ventricular papillary muscle of guinea pig. The onset time of arrhythmia induced by CaCl2 was significantly prolonged by TJ0711 at 0.75, 1.5 and 3 mg x kg(-1) doses. TJ0711 (1.5 and 3 mg x kg(-1)) can significantly shorten the ventricular tachycardia (VT) and ventricular fibrillation (VF) duration, the incidence of VF and mortality were significantly reduced. On ischemia-reperfusion-induced arrhythmic model, TJ0711 (0.25, 0.5, 1 and 2 mg x kg(-1)) can significantly reduce the ventricular premature contraction (PVC), VT, VF incidence, mortality, arrhythmia score with a dose-dependent manner. At the same time, rats serum lactate dehydrogenase (LDH) and creatine kinase (CK) activities decreased significantly by TJ0711 (1 and 2 mg x kg(-1)). Ouabain could cause arrhythmia in guinea pigs, when TJ0711 (0.375, 0.75, 1.5 and 3 mg x kg(-1)) was given, the doses of ouabain inducing a variety of arrhythmia PVC, VT, VF, cardiac arrest (CA) were significantly increased with a dose-dependent manner. In the TJ0711 0.1-30 micromol x L(-1) concentration range, guinea pig right ventricular papillary muscle action potential RP (rest potential), APA (action potential amplitude) and V(max) (maximum velocity of depolarization) were not significantly affected. APD20, APD50 and APD90 had a shortening trend but no statistical difference with the increase of TJ0711 concentration. TJ0711 has antiarrhythmic effect on the sympathetic nerve excitement and myocardial cell high calcium animal arrhythmia model. Myocardial action potential zero phase conduction velocity and resting membrane potential were not inhibited by TJ0711. APD20, APD50 and APD90 were shortened by TJ0711 at high concentration. Its antiarrhythmic action mechanism may be besides the action of blocking beta1 receptor, may also have a strong selective blocking action on alpha1 receptor and reducing intracellular calcium concentration.
Action Potentials
;
drug effects
;
Adrenergic alpha-Antagonists
;
administration & dosage
;
pharmacology
;
Adrenergic beta-Antagonists
;
administration & dosage
;
pharmacology
;
Animals
;
Anti-Arrhythmia Agents
;
administration & dosage
;
pharmacology
;
Arrhythmias, Cardiac
;
blood
;
chemically induced
;
etiology
;
pathology
;
physiopathology
;
Calcium Chloride
;
Creatine Kinase
;
blood
;
Dose-Response Relationship, Drug
;
Female
;
Guinea Pigs
;
Heart Ventricles
;
cytology
;
Lactate Dehydrogenases
;
blood
;
Male
;
Myocardial Reperfusion Injury
;
complications
;
Myocytes, Cardiac
;
drug effects
;
physiology
;
Ouabain
;
Papillary Muscles
;
cytology
;
Phenoxypropanolamines
;
administration & dosage
;
pharmacology
;
Random Allocation
;
Rats
;
Rats, Sprague-Dawley